Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
grade A 15.82 2.06% 0.32
NEO closed up 2.06 percent on Friday, January 18, 2019, on 87 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical NEO trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 Calm After Storm Range Contraction 2.06%
Jan 17 Wide Bands Range Expansion 2.06%
Jan 17 Overbought Stochastic Strength 2.06%
Jan 17 Up 3 Days in a Row Strength 2.06%
Jan 16 Calm After Storm Range Contraction 3.40%
Jan 16 Narrow Range Bar Range Contraction 3.40%

Older signals for NEO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Is NEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.04
52 Week Low 7.08
Average Volume 1,576,831
200-Day Moving Average 13.3768
50-Day Moving Average 14.6504
20-Day Moving Average 13.4385
10-Day Moving Average 14.846
Average True Range 0.6369
ADX 33.24
+DI 34.9851
-DI 14.9145
Chandelier Exit (Long, 3 ATRs ) 14.1093
Chandelier Exit (Short, 3 ATRs ) 12.9607
Upper Bollinger Band 16.6276
Lower Bollinger Band 10.2494
Percent B (%b) 0.87
BandWidth 47.462142
MACD Line 0.4603
MACD Signal Line 0.0637
MACD Histogram 0.3966
Fundamentals Value
Market Cap 1.26 Billion
Num Shares 79.4 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -47.94
Price-to-Sales 2.72
Price-to-Book 4.01
PEG Ratio 3.28
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.63
Resistance 3 (R3) 16.61 16.31 16.50
Resistance 2 (R2) 16.31 16.11 16.33 16.45
Resistance 1 (R1) 16.07 15.98 16.19 16.09 16.40
Pivot Point 15.77 15.77 15.84 15.79 15.77
Support 1 (S1) 15.53 15.57 15.65 15.55 15.24
Support 2 (S2) 15.23 15.44 15.25 15.19
Support 3 (S3) 14.99 15.23 15.15
Support 4 (S4) 15.01